Also indexed as: Phylloquinone, Phytonadione
What does it do?
Vitamin K is needed for proper bone formation and blood clotting. In both cases, vitamin K
does this by helping the body transport calcium. Vitamin K
is used by doctors when treating an overdose of the drug
warfarin. Also, doctors prescribe vitamin K to prevent excessive bleeding in people taking
warfarin but requiring surgery.
There is preliminary evidence that vitamin K2 (menadione), not vitamin K1 (phylloquinone;
phytonadione), may improve a group of blood disorders known as myelodysplastic syndromes
(MDS).1 These syndromes carry a significantly increased risk of progression to
acute myeloid leukemia. Large-scale trials of vitamin K2 for MDS are needed to confirm these
promising early results.
Vitamin K has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Who is likely to be deficient?
A vitamin K deficiency, which causes uncontrolled bleeding, is rare, except in people with
certain malabsorption diseases. However, there are
reports of severe vitamin K deficiency developing in hospitalized patients who had poor food
intake and were receiving antibiotics.4 All
newborn infants receive vitamin K to prevent deficiencies that sometimes develop in breast-fed
infants.
How much is usually taken?
The recommended dietary allowance for vitamin K is about 1 mcg per 2.2 pounds of body
weight per day or about 65 to 80 mcg per day for most adults.5 This level of intake
may be achieved by consuming adequate amounts of leafy
green vegetables. However, studies have shown that many men and women aged 18 to 44 years
ingest less than the recommended amount of vitamin K.6 7
Are there any side effects or interactions?
Allergic reactions to vitamin K injections have been reported on rare
occasions.8
Vitamin K facilitates the effects of calcium in building
bone and proper blood clotting.
Are there any drug
interactions?
Certain medicines may interact with vitamin K. Refer to drug interactions for a list of those medicines.
References
1. Miyazawa K, Nishimaki J, Ohyashiki K, et al. Vitamin K2 therapy for
myelodysplastic syndromes (MDS) and post-MDS acute myeloid leukemia: information through a
questionnaire survey of multi-center pilot studies in Japan. Leukemia
2000;14:1156–7 [letter].
2. Kodaka K, Ujiie T, Ueno T, Saito M. Contents of vitamin K1 and
chlorophyll in green vegetables. J Jpn Soc Nutr Food Sci 1986;39:124–6.
3. Booth SL, Centurelli MA. Vitamin K: a practical guide to the dietary
management of patients on warfarin. Nutr Rev 1999;57:288–96 [review].
4. Pineo GF, Gallus AS, Hirsh J. Unexpected vitamin K deficiency in
hospitalized patients. Can Med Assoc J 1973;109:880–3.
5. Food and Nutrition Board, National Research Council. Recommended
Dietary Allowances, 10th ed. Washington, DC: National Academy Press, 1989.
6. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J
Nutr 2000;130(1S Suppl):785–8.
7. Booth SL, Webb DR, Peters JC. Assessment of phylloquinone and
dihydrophylloquinone dietary intakes among a nationally representative sample of US consumers
using 14-day food diaries. J Am Diet Assoc 1999;99:1072–6.
8. Wong DA, Freeman S. Cutaneous allergic reaction to intramuscular
vitamin K1. Australas J Dermatol 1999;40:147–52.
Copyright © 2004 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires March 2005.
|